RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Transverse Myelitis: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Comment on "The utility of magnetic resonance imaging of the spinal cord in paediatric transverse myelitis: A systematic review".
Meyer Pierre, Multiple sclerosis and related disorders (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42892297/
- 2.
Transverse myelitis as a neurological complication secondary to Leptospira infection in a pediatric patient
Marcia Mendoza Merchan et al., Salud Humana Revista Académica Investigativa (14 October 2026)
https://doi.org/10.54753/rsh.v2i2.2872
- 3.
Sequential occurrence of myasthenia gravis and MOG antibody-associated disease following thymoma resection: an immunopathological perspective
Yun Lu et al., Journal of Medical Case Reports (8 October 2026)
https://doi.org/10.1186/s13256-026-06694-5
- 4.
The utility of magnetic resonance imaging of the spinal cord in paediatric transverse myelitis: A systematic review.
Karia Chiraag Thakrar et al., Multiple sclerosis and related disorders (5 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42858535/
- 5.
ID# 2201788 NOVEL PEDIATRIC SPINAL CORD STIMULATION IN PAINFUL NEUROPATHY FROM SYSTEMIC LUPUS ERYTHEMATOSUS-ASSOCIATED TRANSVERSE MYELITIS
Henry Huang et al., Neuromodulation Technology at the Neural Interface (1 October 2026)
https://doi.org/10.1016/j.neurom.2026.06.359
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Transverse Myelitis
Transverse Myelitis is an inflammatory condition affecting the spinal cord that disrupts the nerve signals running through it, causing weakness, sensory disturbances, and bladder or bowel dysfunction. It can be idiopathic or a manifestation of NMOSD, MS, or other autoimmune diseases. Recovery varies widely from complete to significant permanent disability.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Transverse Myelitis?
Transverse Myelitis is an inflammatory condition affecting the spinal cord that disrupts the nerve signals running through it, causing weakness, sensory disturbances, and bladder or bowel dysfunction. It can be idiopathic or a manifestation of NMOSD, MS, or other autoimmune diseases. Recovery varies widely from complete to significant permanent disability.
How many clinical trials are available for Transverse Myelitis?
RareWays currently indexes 8 clinical trials for Transverse Myelitis, of which 2 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Transverse Myelitis come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Transverse Myelitis.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.